Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04246047
Brief Title: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 7)

First Submitted : January 27, 2020
First Submitted that Met QC Criteria : January 27, 2020
First Posted : January 29, 2020

Last Update Submitted that Met QC Criteria : December 8, 2020
Last Update Posted : December 10, 2020